Richard G. Bach

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction

Sumeet Subherwal, Richard G. Bach, Anita Y. Chen et al. · Circulation · 2009 · 983 citations · Full text

Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement

John A. Spertus, Richard Kettelkamp, Clifton Vance et al. · Circulation · 2006 · 848 citations · Full text

The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support

Amit P. Amin, John A. Spertus, Jeptha P. Curtis et al. · Circulation · 2019 · 395 citations · Full text

The Effect of Routine, Early Invasive Management on Outcome for Elderly Patients with Non–ST-Segment Elevation Acute Coronary Syndromes

Richard G. Bach, Christopher P. Cannon, William S. Weintraub et al. · Annals of Internal Medicine · 2004 · 380 citations